Point of Care Instrument - Atlas io™ Reader Enters Clinical Study Stage
Atlas Genetics Ltd have finished development of the Atlas io™ Reader, a POC device that can deliver laboratory quality results for molecular assays in under thirty minutes.
The Atlas io™ Reader, developed with The Technology Partnership plc operates with a disposable cartridge, to which an unprocessed clinical specimen is added. The instrument fully automates the three-stage process of sample preparation, DNA amplification, and electrochemical detection to analyse the patient’s sample for the target infection.
The Atlas io™ Reader is now entering pilot manufacture ahead of the company conducting clinical studies to support its application for regulatory clearance in Europe later this year.
Tags: Carbapenemase Resistant Enterobacteriaceae (CRE), Clostridium difficile, Methicillin Resistant S. Aureus, Vancomycin Resistant Enterococcus, MRSA, New Delhi Metallo-beta-lactamase NDM-1, Chlamydia, Neisseria, Sepsis
Date Published: January 24, 2014 » company contact details
New Website for C. diff Professionals - www.knowyourpoo.com
CE Marked Test Detects Common Carbapenemase Genes in Under 2.5 Hours
ESwab’s Versatility And Efficacy To Detect MRSA From Nasal Swabs Shown
LiDia® BSI Test: Detection of Pathogens in Clinical Whole Blood Samples